PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW

PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW

ABSTRACT Objective: to identify and synthesize the scientific evidence on cancer patient safety in the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Method: a scoping review, according to the Joanna Briggs Institute and to the recommendations of the PRISMA-ScR international guide. The research was conducted in five electronic databases, the Cochrane Library and eight catalogs of theses and dissertations. The inclusion criteria were the following: studies related to patient safety in the administration of antineoplastic and immunotherapeutic chemotherapy by nurses in places where cancer care occurs, published entirely in Portuguese, Spanish and/or English, with no time limit. The extracted data were analyzed and synthesized in narrative form. Results: a total of 14,444 records were retrieved and 47 studies were kept for review. Most publications (44.7%) had a qualitative approach, while 40.4% were quantitative and 14.9%, mixed. When summarizing the findings, the following themes emerged: Safety standards in parenteral administration of antineoplastic chemotherapy; Good practices for patient safety using oral antineoplastic therapy; Administration and safe handling of immunotherapies; Prevention and management of errors related to the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Conclusion: patients safety with cancer in the administration of antineoplastic therapy occurs when there is implementation of evidence-based protocols, continuing education of nurses and implementation of safety standards and processes, as a strategy to prevent errors in drug administration.

Saved in:
Bibliographic Details
Main Authors: Oliveira,Patrícia Peres de, Santos,Viviane Euzébia Pereira, Bezerril,Manacés dos Santos, Andrade,Fernanda Belmiro de, Paiva,Renilly de Melo, Silveira,Edilene Aparecida Araújo da
Format: Digital revista
Language:English
Published: Universidade Federal de Santa Catarina, Programa de Pós Graduação em Enfermagem 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072019000100506
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-07072019000100506
record_format ojs
spelling oai:scielo:S0104-070720190001005062020-03-06PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEWOliveira,Patrícia Peres deSantos,Viviane Euzébia PereiraBezerril,Manacés dos SantosAndrade,Fernanda Belmiro dePaiva,Renilly de MeloSilveira,Edilene Aparecida Araújo da Drug therapy combination Patient safety Safety Nursing Drug therapy Oncology ABSTRACT Objective: to identify and synthesize the scientific evidence on cancer patient safety in the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Method: a scoping review, according to the Joanna Briggs Institute and to the recommendations of the PRISMA-ScR international guide. The research was conducted in five electronic databases, the Cochrane Library and eight catalogs of theses and dissertations. The inclusion criteria were the following: studies related to patient safety in the administration of antineoplastic and immunotherapeutic chemotherapy by nurses in places where cancer care occurs, published entirely in Portuguese, Spanish and/or English, with no time limit. The extracted data were analyzed and synthesized in narrative form. Results: a total of 14,444 records were retrieved and 47 studies were kept for review. Most publications (44.7%) had a qualitative approach, while 40.4% were quantitative and 14.9%, mixed. When summarizing the findings, the following themes emerged: Safety standards in parenteral administration of antineoplastic chemotherapy; Good practices for patient safety using oral antineoplastic therapy; Administration and safe handling of immunotherapies; Prevention and management of errors related to the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Conclusion: patients safety with cancer in the administration of antineoplastic therapy occurs when there is implementation of evidence-based protocols, continuing education of nurses and implementation of safety standards and processes, as a strategy to prevent errors in drug administration.info:eu-repo/semantics/openAccessUniversidade Federal de Santa Catarina, Programa de Pós Graduação em EnfermagemTexto & Contexto - Enfermagem v.28 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072019000100506en10.1590/1980-265x-tce-2018-0312
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Oliveira,Patrícia Peres de
Santos,Viviane Euzébia Pereira
Bezerril,Manacés dos Santos
Andrade,Fernanda Belmiro de
Paiva,Renilly de Melo
Silveira,Edilene Aparecida Araújo da
spellingShingle Oliveira,Patrícia Peres de
Santos,Viviane Euzébia Pereira
Bezerril,Manacés dos Santos
Andrade,Fernanda Belmiro de
Paiva,Renilly de Melo
Silveira,Edilene Aparecida Araújo da
PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
author_facet Oliveira,Patrícia Peres de
Santos,Viviane Euzébia Pereira
Bezerril,Manacés dos Santos
Andrade,Fernanda Belmiro de
Paiva,Renilly de Melo
Silveira,Edilene Aparecida Araújo da
author_sort Oliveira,Patrícia Peres de
title PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
title_short PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
title_full PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
title_fullStr PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
title_full_unstemmed PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
title_sort patient safety in the administration of antineoplastic chemotherapy and of immunotherapics for oncological treatment: scoping review
description ABSTRACT Objective: to identify and synthesize the scientific evidence on cancer patient safety in the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Method: a scoping review, according to the Joanna Briggs Institute and to the recommendations of the PRISMA-ScR international guide. The research was conducted in five electronic databases, the Cochrane Library and eight catalogs of theses and dissertations. The inclusion criteria were the following: studies related to patient safety in the administration of antineoplastic and immunotherapeutic chemotherapy by nurses in places where cancer care occurs, published entirely in Portuguese, Spanish and/or English, with no time limit. The extracted data were analyzed and synthesized in narrative form. Results: a total of 14,444 records were retrieved and 47 studies were kept for review. Most publications (44.7%) had a qualitative approach, while 40.4% were quantitative and 14.9%, mixed. When summarizing the findings, the following themes emerged: Safety standards in parenteral administration of antineoplastic chemotherapy; Good practices for patient safety using oral antineoplastic therapy; Administration and safe handling of immunotherapies; Prevention and management of errors related to the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Conclusion: patients safety with cancer in the administration of antineoplastic therapy occurs when there is implementation of evidence-based protocols, continuing education of nurses and implementation of safety standards and processes, as a strategy to prevent errors in drug administration.
publisher Universidade Federal de Santa Catarina, Programa de Pós Graduação em Enfermagem
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072019000100506
work_keys_str_mv AT oliveirapatriciaperesde patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
AT santosvivianeeuzebiapereira patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
AT bezerrilmanacesdossantos patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
AT andradefernandabelmirode patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
AT paivarenillydemelo patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
AT silveiraedileneaparecidaaraujoda patientsafetyintheadministrationofantineoplasticchemotherapyandofimmunotherapicsforoncologicaltreatmentscopingreview
_version_ 1756408056995905536

Similar Items